Patent · US Active

Methods of preventing platelet activation

US11400103B2 · kind B2 · utility

0Cited by

5References

20Claims

0Family size

Assignee

VANDERBILT UNIVERSITY · US

Inventors

John A. Oates · Nashville, US
Olivier Boutaud · Nashville, US
Irene Zagol-Ikapitte · Nashville, US

Key dates

Filing date	Apr 17, 2020
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Apr 17, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of preventing or reducing the occurrence of malondiadehyde and/or levuglandin protein modification in a subject in need thereof, comprising administering to said subject an effective amount of at least one reactive dicarbonyl scavenger compound, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.